Publicacións en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (21)

2024

  1. Signature Proteins in Small Extracellular Vesicles of Granulocytes and CD4+ T-Cell Subpopulations Identified by Comparative Proteomic Analysis

    International Journal of Molecular Sciences, Vol. 25, Núm. 19

2023

  1. Genomics, biofilm formation and infection of bladder epithelial cells in potentially uropathogenic Escherichia coli (UPEC) from animal sources and human urinary tract infections (UTIs) further support food-borne transmission

    One Health, Vol. 16

  2. Identification of Asthma Phenotypes in the Spanish MEGA Cohort Study Using Cluster Analysis

    Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 223-231

  3. Serum exosome inflamma-miRs are surrogate biomarkers for asthma phenotype and severity

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 1, pp. 141-155

2022

  1. Association of rhinitis with asthma prevalence and severity

    Scientific Reports, Vol. 12, Núm. 1

  2. Correction to: Impact of anxiety and depression on the prognosis of copd exacerbations (BMC Pulmonary Medicine, (2022), 22, 1, (169), 10.1186/s12890-022-01934-y)

    BMC Pulmonary Medicine

  3. Risk Factors of Mortality in Hospitalized Patients With COVID-19 Applying a Machine Learning Algorithm

    Open Respiratory Archives, Vol. 4, Núm. 2

  4. The polyhedric reality of the interaction between COVID-19, asthma and inhaled corticosteroids

    ERJ Open Research

2021

  1. Clinical and inflammatory characteristics of patients with asthma in the Spanish MEGA project cohort

    Clinical and Translational Allergy, Vol. 11, Núm. 1

  2. Igf1r as a potential pharmacological target in allergic asthma

    Biomedicines, Vol. 9, Núm. 8

2020

  1. Beneficial effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe COVID-19 illness

    International Journal of Infectious Diseases, Vol. 101, pp. 290-297

  2. Obesity does not increase the risk of Asthma readmissions

    Journal of Clinical Medicine, Vol. 9, Núm. 1

  3. iTRAQ-based proteomic analysis reveals potential serum biomarkers of allergic and nonallergic asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 12, pp. 3171-3183

2019

  1. Expansion of different subpopulations of CD26 −/low T cells in allergic and non-allergic asthmatics

    Scientific Reports, Vol. 9, Núm. 1

  2. Blood eosinophils could be useful as a biomarker in chronic obstructive pulmonary disease exacerbations

    International Journal of Clinical Practice, Vol. 73, Núm. 12

2018

  1. Association between blood eosinophil count with asthma hospital readmissions

    European Journal of Internal Medicine, Vol. 53, pp. 34-39

  2. Expansion of a CD26low effector th subset and reduction in circulating levels of sCD26 in stable allergic asthma in adults

    Journal of Investigational Allergology and Clinical Immunology, Vol. 28, Núm. 2, pp. 113-125

  3. The CD14 (-159 C/T) SNP is associated with sCD14 levels and allergic asthma, but not with CD14 expression on monocytes

    Scientific Reports, Vol. 8, Núm. 1

  4. The MEGA Project: A Study of the Mechanisms Involved in the Genesis and Disease Course of Asthma. Asthma Cohort Creation and Long-Term Follow-Up

    Archivos de Bronconeumologia, Vol. 54, Núm. 7, pp. 378-385

2017

  1. Asthma exacerbations: factors related to longer hospital stay

    Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine, Vol. 72, Núm. 6, pp. 379-384